DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /QuinolinesQuinolines
  6. /EzurpimtrostatEzurpimtrostat
Chemical structure of CAS 1914148-72-3

Ezurpimtrostat

In Stock•Starting at $99 for 10 mg•Purity ≥ 98%
CAS No.1914148-72-3
MDL No.N/A
MFC25H31ClN4
MW423.00
InChI KeyQVXSJSXAVQJXOV-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
10 mg98%$99In Stock
25 mg98%$177In Stock
50 mg98%$247In Stock
100 mg98%$370In Stock
250 mg98%$655In Stock
1 g98%$1494In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1914148-72-3
Product NameEzurpimtrostat

Associated Conditions

hepatocellular carcinoma·COVID-19·liver cancer·cholangiocarcinoma
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Divergent effects of acute and chronic PPT1 inhibition in melanoma.

Autophagy • Vol. 21, Issue 2 • 2025
PMID: 39265628PMC: PMC11760279DOI: 10.1080/15548627.2024.2403152

Novel quinoline substituted autophagy inhibitors attenuate Zika virus replication in ocular cells.

Virus research • Vol. 347 • 2024
PMID: 38880335PMC: PMC11239713DOI: 10.1016/j.virusres.2024.199419

Ezurpimtrostat, A Palmitoyl-Protein Thioesterase-1 Inhibitor, Combined with PD-1 Inhibition Provides CD8 Lymphocyte Repopulation in Hepatocellular Carcinoma.

Targeted oncology • Vol. 19, Issue 1 • 2024
PMID: 38133710DOI: 10.1007/s11523-023-01019-8

Update on Autophagy Inhibitors in Cancer: Opening up to a Therapeutic Combination with Immune Checkpoint Inhibitors.

Cells • Vol. 12, Issue 13 • 2023
PMID: 37443736PMC: PMC10341243DOI: 10.3390/cells12131702

Documentation

Similar Products

  • Ezurpimtrostat hydrochloride

    CAS No.1914148-73-4

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact